<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03731065</url>
  </required_header>
  <id_info>
    <org_study_id>MSES 17/18-001</org_study_id>
    <nct_id>NCT03731065</nct_id>
  </id_info>
  <brief_title>Exogenous Oxidation of Fructose-glucose Mixtures During Running</brief_title>
  <official_title>Examining Exogenous Carbohydrate Oxidation From Glucose, Multiple Transportable Carbohydrates and Hydrogel Carbohydrate Drinks During Endurance Running</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Bath</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Birmingham</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Bath</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to characterise exogenous carbohydrate oxidation rates during
      exercise, when ingesting glucose (polymers) only, compared to glucose-fructose mixtures, and
      glucose-fructose mixtures ingested in hydrogel form.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 14, 2018</start_date>
  <completion_date type="Actual">November 30, 2019</completion_date>
  <primary_completion_date type="Actual">October 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Peak exogenous carbohydrate oxidation rate</measure>
    <time_frame>120 minutes</time_frame>
    <description>Peak exogenous carbohydrate oxidation rate during 120 min of treadmill running. Measured using isotope ratio mass spectrometry and reported in grams per minute</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total carbohydrate oxidation</measure>
    <time_frame>120 minutes</time_frame>
    <description>Total carbohydrate oxidation during 120 min of treadmill running. Measured using indirect calorimetry and reported in grams.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ratings of gastrointestinal discomfort</measure>
    <time_frame>120 minutes</time_frame>
    <description>Subjective ratings of gastrointestinal discomfort during 120 min of treadmill running. Measured using a 9-item questionnaire on a scale of 1 to 7, where 1 = No discomfort at all and 7 = very severe discomfort.
Items: Stomach; Heartburn; Acid reflux; Nausea; Rumbling; Bloated; Burping; Passing gas; Bowel movement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total fat oxidation</measure>
    <time_frame>120 minutes</time_frame>
    <description>Total fat oxidation during 120 min of treadmill running. Measured using indirect calorimetry and reported in grams.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma insulin concentrations</measure>
    <time_frame>120 minutes</time_frame>
    <description>Plasma insulin concentrations during 120 min of treadmill running. Measured using enzyme-linked immunosorbent assay and reported in pmol/L.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma glucose concentrations</measure>
    <time_frame>120 minutes</time_frame>
    <description>Plasma lactate concentrations during 120 min of treadmill running. Measured using colourimetric assay and reported in mmol/L.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma lactate concentrations</measure>
    <time_frame>120 minutes</time_frame>
    <description>Plasma lactate concentrations during 120 min of treadmill running. Measured using colourimetric assay and reported in mmol/L.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma non-esterified fatty acid concentrations</measure>
    <time_frame>120 minutes</time_frame>
    <description>Plasma insulin concentrations during 120 min of treadmill running. Measured using colourimetric assay and reported in umol/L.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ratings of perceived exertion</measure>
    <time_frame>120 minutes</time_frame>
    <description>Subjective ratings of perceived exertion using the Borg scale (1982) during 120 min of treadmill running. Measured on a scale of 6 to 20, where 6 = no exertion at all, and 20 = maximal exertion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>120 minutes</time_frame>
    <description>Heart rate during treadmill running measured by telemetry and reported in beats per minute.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of oxygen consumption</measure>
    <time_frame>120 minutes</time_frame>
    <description>Rate of oxygen consumption during 120 min of treadmill running. Measured using indirect calorimetry and reported in litres per minute.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of carbon dioxide production</measure>
    <time_frame>120 minutes</time_frame>
    <description>Rate of carbon dioxide production during 120 min of treadmill running. Measured using indirect calorimetry and reported in litres per minute.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">9</enrollment>
  <condition>Exercise</condition>
  <arm_group>
    <arm_group_label>Fructose-maltodextrin ingestion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ingestion of fructose and maltodextrin (glucose polymers) at a rate of 90 g carbohydrate per hour during two hours of treadmill running at 60%VO2peak.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fructose-maltodextrin hydrogel ingestion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ingestion of fructose and maltodextrin (glucose polymers) encapsulated in alginate-pectin hydrogel, drinks at a rate of 90 g carbohydrate per hour during two hours of treadmill running at 60%VO2peak.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Glucose-maltodextrin ingestion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ingestion of glucose and maltodextrin (glucose polymers) at a rate of 90 g carbohydrate per hour during two hours of treadmill running at 60%VO2peak.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fructose-maltodextrin</intervention_name>
    <description>Fructose plus maltodextrin in a ratio of 1:1.4, diluted in water to produce a 16% carbohydrate solution.</description>
    <arm_group_label>Fructose-maltodextrin ingestion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fructose-maltodextrin hydrogel</intervention_name>
    <description>Fructose plus maltodextrin in a ratio of 1:1.4, encapsulated in an alginate-pectin hydrogel diluted in water to produce a 16% carbohydrate solution.</description>
    <arm_group_label>Fructose-maltodextrin hydrogel ingestion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Glucose-maltodextrin</intervention_name>
    <description>Glucose plus maltodextrin in a ratio of 1:1.4, diluted in water to produce a 16% carbohydrate solution.</description>
    <arm_group_label>Glucose-maltodextrin ingestion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Maximal oxygen consumption &gt; 50 ml.kg-1.min-1

          -  &gt; 1 year training in endurance running or triathlon

          -  No current injury or injury within the last three months

          -  No history of cardiac or metabolic disease such as coronary heart disease or diabetes

          -  No current or history of gastrointestinal issues

          -  Successful completion of the physical activity readiness questionnaire (PAR-Q)

        Exclusion Criteria:

          -  Female

          -  Untrained in endurance running

          -  Current injury or injury within the past three months

          -  History of cardiac or metabolic disease such as coronary heart disease or diabetes

          -  History of or current gastrointestinal issues such as irritable bowel syndrome

          -  Unable to replicate diet and training for 3 and 5 days respectively prior to each
             experimental visit.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department for Health, University of Bath</name>
      <address>
        <city>Bath</city>
        <zip>BA2 7AY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>November 2, 2018</study_first_submitted>
  <study_first_submitted_qc>November 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2018</study_first_posted>
  <last_update_submitted>December 7, 2019</last_update_submitted>
  <last_update_submitted_qc>December 7, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Bath</investigator_affiliation>
    <investigator_full_name>Javier Gonzalez</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

